
The first comprehensive survey of viruses found with different types of cancer has been conducted by researchers. Researchers from the …

Over a thousand scientists have built the most detailed picture of cancer ever in a landmark study. Their research was …

Biogen has emerged victorious in a patent dispute with Mylan relating to the latter’s multiple sclerosis therapy Tecfidera – a …

A baby born this month in Wuhan China has been diagnosed with the coronavirus. The child was born 2 February, …
Clinical trials are one of the longest and most expensive steps of bringing a drug to market. Conor Kavanagh investigates …

The British National Institute for Care Excellence has said it plans to use a broader range of data and analytics …

Bayer has pulled back the curtain on new Phase 4 data for Eylea (aflibercept), revealing strong findings in the treatment …

The last flight from Wuhan will arrive back in the UK on Sunday, bringing back British nationals fleeing from the …

The FDA has just approved the first adjuvanted, cell-based vaccine for the prevention of influenza A (H5N1) in the US, …

The UK faces a new Sexually Transmitted Infection (STI) diagnoses every 70 seconds, according to a new report that outlines …

A recent review of clinical trials shows that first-line psychotherapies are limited in how effectively they treat veterans with PTSD.

The EMA’s Committee for Medicinal Products for Human Use (CHMP) has revealed that it has awarded a positive opinion for …

Sanofi has been charged with failure to adequately warn patients about their anti-epilepsy drug which has been linked to birth …

A trial investigating the efficacy of a new HIV vaccine conducted by the National Institute of Allergy and Infectious Diseases …

In a rare move, China’s leadership has admitted “shortcomings” in the way it has handled the outbreak of the deadly …

Rodrigo Gribble, Vice President Cardiovascular at AstraZeneca, breaks down recently published data from the PEGASUS trial of ticagrelor, a potential …

China and the US are testing Gilead’s remdesivir in patients with the coronavirus, in the hopes of developing an effective …

Bristol-Myers Squibb has confirmed it has withdrawn its application with the European Commission for its combination of Opdivo (nivolumab) and …

More Britons have been flown back from Wuhan, the heart of the coronavirus outbreak, while the UK government has donated …

The European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) has awarded recommendation to AbbVie’s Venclyxto (venetoclax), …